Filing Details
- Accession Number:
- 0001349929-15-000058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-16 08:26:00
- Reporting Period:
- 2015-11-12
- Filing Date:
- 2015-11-16
- Accepted Time:
- 2015-11-16 08:26:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1349929 | Cancer Genetics Inc | CGIX | Services-Medical Laboratories (8071) | 043462475 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
897464 | John Pappajohn | 201 Route 17 North 2Nd Floor Rutherford NJ 07070 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2015-11-12 | 100,000 | $0.00 | 1,621,789 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share | Warrant (right to buy) | Acquisiton | 2015-11-12 | 100,000 | $0.00 | 100,000 | $5.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
100,000 | 2015-11-12 | 2020-11-12 | No | 4 | P | Direct |
Footnotes
- The reported securities were purchased in an underwritten public offering which closed on November 12, 2015. The reported securities were issued pursuant to a prospectus supplement in connection with a takedown from the Company's shelf registration statement on Form S-3 (File No. 333-196374), filed with the SEC and effective on June 5, 2014.
- The reported securities consist of one share of common stock, par value $0.0001 per share (the "Common Stock") and an accompanying warrant to purchase one share of Common Stock for $4.00 per share and warrant.